ENDRA Life Sciences Inc (NASDAQ:NDRA) — Market Cap & Net Worth
Market Cap & Net Worth: ENDRA Life Sciences Inc (NDRA)
ENDRA Life Sciences Inc (NASDAQ:NDRA) has a market capitalization of $8.68 Million ($8.68 Million) as of September 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #27508 globally and #5678 in its home market, demonstrating a -9.13% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ENDRA Life Sciences Inc's stock price $5.87 by its total outstanding shares 1499838 (1.50 Million). Also see ENDRA Life Sciences Inc assets under control for a full breakdown of the balance sheet.
ENDRA Life Sciences Inc Market Cap History: 2017 to 2026
ENDRA Life Sciences Inc's market capitalization history from 2017 to 2026. Data shows change from $12.76 Billion to $8.80 Million (-53.52% CAGR). Also see ENDRA Life Sciences Inc cash conversion from operations for how efficiently the company converts equity into cash flow.
Index Memberships
ENDRA Life Sciences Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.66 Trillion | 0.00% | #788 of 976 |
|
NASDAQ Composite
IXIC
|
$41.69 Trillion | 0.00% | #2538 of 3165 |
Weight: ENDRA Life Sciences Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
ENDRA Life Sciences Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ENDRA Life Sciences Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check ENDRA Life Sciences Inc (NDRA) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
637686.22x
ENDRA Life Sciences Inc's market cap is 637686.22 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $12.76 Billion | $351.62K | -$5.38 Million | 36280.18x | N/A |
| 2018 | $3.94 Billion | $6.17K | -$9.80 Million | 637686.22x | N/A |
Competitor Companies of NDRA by Market Capitalization
Companies near ENDRA Life Sciences Inc in the global market cap rankings as of September 17, 2026. Review ENDRA Life Sciences Inc tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to ENDRA Life Sciences Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #89 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #163 globally with a market cap of $147.17 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #472 globally with a market cap of $57.08 Billion USD ( CN¥390.06 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #577 globally with a market cap of $47.01 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #89 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $648.43 |
| #163 | Danaher Corporation | NYSE:DHR | $147.17 Billion | $208.36 |
| #472 | WuXi AppTec Co Ltd | SHG:603259 | $57.08 Billion | CN¥157.71 |
| #577 | Natera Inc | NASDAQ:NTRA | $47.01 Billion | $345.34 |
ENDRA Life Sciences Inc Historical Marketcap From 2017 to 2026
Between 2017 and today, ENDRA Life Sciences Inc's market cap moved from $12.76 Billion to $ 8.80 Million, with a yearly change of -53.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $8.80 Million | +29.58% |
| 2025 | $6.79 Million | -27.64% |
| 2024 | $9.39 Million | -99.83% |
| 2023 | $5.56 Billion | -47.91% |
| 2022 | $10.68 Billion | +488.32% |
| 2021 | $1.82 Billion | -7.76% |
| 2020 | $1.97 Billion | -55.36% |
| 2019 | $4.41 Billion | +12.00% |
| 2018 | $3.94 Billion | -69.14% |
| 2017 | $12.76 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of ENDRA Life Sciences Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.68 Million USD |
| MoneyControl | $8.68 Million USD |
| MarketWatch | $8.68 Million USD |
| marketcap.company | $8.68 Million USD |
| Reuters | $8.68 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ENDRA Life Sciences Inc
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fa… Read more